Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 79

1.

Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials.

van Eijk RPA, Jones AR, Sproviero W, Shatunov A, Shaw PJ, Leigh PN, Young CA, Shaw CE, Mora G, Mandrioli J, Borghero G, Volanti P, Diekstra FP, van Rheenen W, Verstraete E, Eijkemans MJC, Veldink JH, Chio A, Al-Chalabi A, van den Berg LH, van Es MA; For UKMND-LiCALS and LITALS Study Group.

Neurology. 2017 Oct 31;89(18):1915-1922. doi: 10.1212/WNL.0000000000004606. Epub 2017 Oct 4. Review. Erratum in: Neurology. 2017 Nov 28;89(22):2303.

2.

Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial.

PD Med Collaborative Group, Gray R, Ives N, Rick C, Patel S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE.

Lancet. 2014 Sep 27;384(9949):1196-205. doi: 10.1016/S0140-6736(14)60683-8. Epub 2014 Jun 11. Erratum in: Lancet. 2014 Sep 27;384(9949):1186.

PMID:
24928805
3.

Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial.

UKMND-LiCALS Study Group, Morrison KE, Dhariwal S, Hornabrook R, Savage L, Burn DJ, Khoo TK, Kelly J, Murphy CL, Al-Chalabi A, Dougherty A, Leigh PN, Wijesekera L, Thornhill M, Ellis CM, O'Hanlon K, Panicker J, Pate L, Ray P, Wyatt L, Young CA, Copeland L, Ealing J, Hamdalla H, Leroi I, Murphy C, O'Keeffe F, Oughton E, Partington L, Paterson P, Rog D, Sathish A, Sexton D, Smith J, Vanek H, Dodds S, Williams TL, Steen IN, Clarke J, Eziefula C, Howard R, Orrell R, Sidle K, Sylvester R, Barrett W, Merritt C, Talbot K, Turner MR, Whatley C, Williams C, Williams J, Cosby C, Hanemann CO, Iman I, Philips C, Timings L, Crawford SE, Hewamadduma C, Hibberd R, Hollinger H, McDermott C, Mils G, Rafiq M, Shaw PJ, Taylor A, Waines E, Walsh T, Addison-Jones R, Birt J, Hare M, Majid T.

Lancet Neurol. 2013 Apr;12(4):339-45. doi: 10.1016/S1474-4422(13)70037-1. Epub 2013 Feb 27. Erratum in: Lancet Neurol. 2013 Sep;12(9):846.

4.

Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic lateral sclerosis (LiCALS) [Eudract number: 2008-006891-31].

Al-Chalabi A, Shaw PJ, Young CA, Morrison KE, Murphy C, Thornhill M, Kelly J, Steen IN, Leigh PN; UKMND-LiCALS.

BMC Neurol. 2011 Sep 21;11:111. doi: 10.1186/1471-2377-11-111.

5.

Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.

Brown RG, Lacomblez L, Landwehrmeyer BG, Bak T, Uttner I, Dubois B, Agid Y, Ludolph A, Bensimon G, Payan C, Leigh NP; NNIPPS Study Group.

Brain. 2010 Aug;133(Pt 8):2382-93. doi: 10.1093/brain/awq158. Epub 2010 Jun 24.

PMID:
20576697
6.

Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study.

Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN; NNIPPS Study Group.

Brain. 2009 Jan;132(Pt 1):156-71. doi: 10.1093/brain/awn291. Epub 2008 Nov 23.

7.

The natural history of multiple sclerosis: a regional study with some longitudinal data.

Miller DH, Hornabrook RW, Purdie G.

J Neurol Neurosurg Psychiatry. 1992 May;55(5):341-6.

8.

Frequent involvement of the optic radiation in patients with acute isolated optic neuritis.

Hornabrook RS, Miller DH, Newton MR, MacManus DG, du Boulay GH, Halliday AM, McDonald WI.

Neurology. 1992 Jan;42(1):77-9.

PMID:
1734327
9.

Class II HLA antigens in multiple sclerosis.

Miller DH, Hornabrook RW, Dagger J, Fong R.

J Neurol Neurosurg Psychiatry. 1989 May;52(5):575-7.

10.

Comparison of mefenamic acid and propranolol with placebo in migraine prophylaxis.

Johnson RH, Hornabrook RW, Lambie DG.

Acta Neurol Scand. 1986 May;73(5):490-2.

PMID:
3524092
11.

Ethnic and HLA patterns related to multiple sclerosis in Wellington, New Zealand.

Miller DH, Hornabrook RW, Dagger J, Fong R.

J Neurol Neurosurg Psychiatry. 1986 Jan;49(1):43-6.

12.

Gliomatosis cerebri--report of a case.

Balakrishnan V, Hornabrook RW, Alexander WS.

Pathology. 1985 Jan;17(1):123-6.

PMID:
4000710
13.

Studies of endemic cretinism in Papua New Guinea: digital and palmar dermatoglyphic patterns.

Larrick JW, Plato CC, Hornabrook RW.

Am J Phys Anthropol. 1983 Jun;61(2):205-10.

PMID:
6881322
14.

Red cell antigen, serum protein and red cell enzyme polymorphisms in Karkar Islanders and inhabitants of the adjacent North Coast of New Guinea.

Booth PB, Tills D, Warlow A, Kopeć AC, Mourant AE, Teesdale P, Hornabrook RW.

Hum Hered. 1982;32(6):385-403.

PMID:
6218066
15.

Red cell antigen, serum protein and red cell enzyme polymorphisms in Eastern Highlanders of New Guinea.

Mourant AE, Tills D, Kopeć AC, Warlow A, Teesdale P, Booth PB, Hornabrook RW.

Hum Hered. 1982;32(6):374-84.

PMID:
6218065
16.

Sodium valproate in pregnancy.

Cairney P, Hornabrook RW, Ainsworth JW.

N Z Med J. 1981 Sep 23;94(692):238. No abstract available.

PMID:
6795550
17.

Genetic surveys from the Central, Morobe and Northern Districts, Papua New Guinea.

Booth PB, Mourant AE, Tills D, Kopeć AC, Warlow A, Teesdale P, Hornabrook RW, Crane GG, Saave JJ.

Ann Hum Biol. 1981 Sep-Oct;8(5):435-45.

PMID:
7294721
18.

Red cell antigen, serum protein, and red cell enzyme polymorphisms in inhabitants of the Jimi Valley, Western Highlands, New Guinea.

Mourant AE, Tills D, Kopeć AC, Warlow A, Teesdale P, Booth PB, Hornabrook RW.

Hum Genet. 1981;59(1):77-80.

PMID:
10819028
19.

Congenital nystagmus among the Red-skins of the Highlands of Papua New Guinea.

Hornabrook RW, McDonald WI, Carroll RL.

Br J Ophthalmol. 1980 May;64(5):375-80.

20.

Granulomatous angiitis of the CNS.

Sandhu R, Alexander WS, Hornabrook RW, Stehbens WE.

Arch Neurol. 1979 Jul;36(7):433-5.

PMID:
36873

Supplemental Content

Loading ...
Support Center